Remove Biotech Remove Competitive Remove Innovation
article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations.

Biotech 487
article thumbnail

Top 10 countries attracting international tech talent

CIO

These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance. The Netherlands The Netherlands is home to a rapidly growing tech industry, in particular, in Amsterdam, which boasts several innovation hubs, according to EuroNews.

Startups 516
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.

Biotech 98
article thumbnail

From Hype to Reality: Top Trends Driving the Future of Generative AI

SCIP

By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge. Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine.

SCIP 40
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9

Biotech 96
article thumbnail

Top IPOs to Watch in 2025 | APAC Region

Alpha Sense BI

Hengrui has transitioned from a generic drug manufacturer to a major player in oncology, immunotherapy, and innovative treatments, investing heavily in global R&D infrastructure. Owned by Globe Fintech Innovations (Mynt), GCash has over 80 million users and dominates the countrys mobile payments, lending, and financial services space.

article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Sponsor deals rebounded exceptionally.

Capital 98